PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.75%
Negative revenue growth while EXP stands at 8.29%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-71.54%
Negative gross profit growth while EXP is at 30.98%. Joel Greenblatt would examine cost competitiveness or demand decline.
-93.45%
Negative EBIT growth while EXP is at 31.20%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-93.45%
Negative operating income growth while EXP is at 31.20%. Joel Greenblatt would press for urgent turnaround measures.
-7.86%
Negative net income growth while EXP stands at 24.10%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
5.56%
EPS growth under 50% of EXP's 26.56%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
5.56%
Diluted EPS growth under 50% of EXP's 25.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-11.52%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-11.51%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
277.81%
10Y revenue/share CAGR at 75-90% of EXP's 326.14%. Bill Ackman would press for new markets or product lines to narrow the gap.
84.68%
5Y revenue/share CAGR at 50-75% of EXP's 130.30%. Martin Whitman would worry about a lagging mid-term growth trajectory.
80.61%
3Y revenue/share CAGR 1.25-1.5x EXP's 69.63%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
169.86%
Below 50% of EXP's 431.14%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
141.24%
5Y net income/share CAGR 1.25-1.5x EXP's 114.23%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
184.47%
3Y net income/share CAGR similar to EXP's 179.76%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
134.52%
5Y equity/share CAGR above 1.5x EXP's 39.55%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
59.46%
3Y equity/share CAGR above 1.5x EXP's 16.81%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.